4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000047
Chief Operating Officer sold 7,097 shares at an average $18.03 ($127,938)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J Chief Operating Officer | 2023-07-10 | Sale 10b5-1 | −3,200 | $18.00 | $57,605 | 39,273 | D: show line 1 in the form |
| Dowden Nathan J Chief Operating Officer | 2023-07-11 | Sale 10b5-1 | −3,897 | $18.05 | $70,333 | 35,376 | D: show line 2 in the form |
| Open-market sales · 7,097 sh · avg $18.03 · $127,938 | |||||||
Loading xslF345X04/wf-form4_168919399033901.xml…